Cause of Death in Patients with Squamous Cell Lung Cancer (SCC) Treated with Surgery

被引：0
|
作者：
Antao, N. [1 ]
Samson, P. [2 ]
Pellini, B. [3 ]
Waqar, S. [3 ]
Devarakonda, S. [3 ]
Ward, J. [3 ]
Govindan, R. [4 ]
Morgensztern, D. [3 ]
机构：
[1] John Cochran Vet Hosp, Internal Med, St Louis, MO USA
[2] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA
[3] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA
[4] Siteman Canc Ctr, St Louis, MO USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Squamous cell lung cancer; SEER; cause of death;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P09.26
引用
收藏
页码：S301 / S302
页数：2
相关论文
共 50 条
  • [31] CYFRA 21-1, SCC-Ag, CEA and selected biochemical factors of cachexia in patients with squamous cell lung cancer
    Wójcik, E
    Stasik, Z
    Reinfuss, M
    Kolodziejski, L
    Kulpa, J
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 422 - 422
  • [32] Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung
    Levy, Benjamin Philip
    Paz-Ares, Luis G.
    Bennouna, Jaafar
    Felip, Enriqueta
    Abreu, Delvys Rodriguez
    Isla, Dolores
    Barlesi, Fabrice
    Molinier, Olivier
    Madelaine, Jeannick
    Audigier-Valette, Clarisse
    Kim, Sang-We
    Ozguroglu, Mustafa
    Erman, Mustafa
    Badin, Firas Benyamine
    Mekhail, Tarek
    Scheff, Ronald J.
    Riess, Jonathan W.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] METASTASIS IN PATIENTS TREATED FOR LUNG-CANCER BY CURATIVE SURGERY
    SUEMASU, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1981, 11 : 167 - 171
  • [34] Is the second primary malignancy an important competing cause of death in patients (pts) with squamous cell head and neck cancer (SCHNC)?
    Tso, E
    Adelstein, DJ
    Rybicki, LA
    Saxton, JP
    Esclamado, RM
    Wood, BG
    Strome, M
    Carroll, MA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 492S - 492S
  • [35] Clinical value of squamous cell carcinoma antigen (SCC-A) in Egyptian gynecologic cancer patients
    Salman, T
    ElAhmady, O
    Tony, O
    Darwish, M
    ANTICANCER RESEARCH, 1997, 17 (4B) : 3083 - 3086
  • [36] CLINICAL UTILITY OF SQUAMOUS-CELL CARCINOMA ANTIGEN (SCC) IN PATIENTS WITH CERVICAL-CANCER
    SPENCER, C
    SHAW, N
    DEPETRILLO, AD
    MORROW, CP
    SENEKJIAN, EK
    SHINGLETON, HM
    TUMOUR BIOLOGY, 1986, 7 (04): : 268 - 268
  • [37] How can we quantify the risk of squamous cell cancer (SCC) and death in transplanted versus non transplanted patients with Fanconi anemia (FA)?
    Socie, G
    Rosenberg, PS
    Gluckman, E
    Alter, BP
    BLOOD, 2003, 102 (11) : 979A - 979A
  • [38] Safety and efficacy of erlotinib in patients with squamous cell lung cancer
    Jakopovic, Marko
    Cucevic, Branka
    Plestina, Sanja
    Smojver-Jezek, Silvana
    Kukulj, Suzana
    Chalfe, Nabil
    Korsic, Marta
    Vrbica, Zarko
    Redzepi, Gzim
    Samarzija, Miroslav
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [39] Efficacy of gefitinib or erlotinib in patients with squamous cell lung cancer
    Song, Zhengbo
    Zhang, Yiping
    ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (01) : 164 - 168
  • [40] Multiple squamous cell carcinomas in situ in a patient with lung cancer treated with tepotinib
    Okazaki, Toshiki
    Fujimura, Taku
    Asano, Yoshihide
    EUROPEAN JOURNAL OF DERMATOLOGY, 2024, 34 (03) : 313 - 314
12345